Cancer nanotechnology: opportunities and challenges
By Mauro Ferrari. Nature Reviews. Cancer, 2005
4,406 citations recorded by the source corpus.
Subfields: Biomedical Engineering, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/7ba37494ac59afa65acca09a2334a3eb1eafde03
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomedical Engineering
- Charles M. Lieber
- F. Patolsky
- Gengfeng Zheng
- R. Taylor
- Kostas Kostarelos
- S. Mitragotri
- N. Bertrand
- M. Prato
In Molecular Biology
- O. Farokhzad
- N. Bertrand
- Kostas Kostarelos
- Robert Langer
- M. Prato
- D. Schmaljohann
- Joon Won Park
- Young-Eun Choi
Citations in the corpus
- PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. (2009, background): “Concurrently, the development of biodegradable polymeric NPs in the w100 nm range has become an increasingly exciting field in academic and industrial research [2,3].”
- Biogenic Synthesis of Nanoparticles and Potential Applications: An Eco- Friendly Approach (2013, background): “The exclusive properties and usefulness of nanoparticles arise from a variety of aspects, including the similar size of nanoparticles and biomolecules, such as proteins and polynucleic acids [3].”
- Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. (2009, background): “A dvanced drug delivery systems (DDS) hold great promise for improving cancer therapy outcomes.(1) Anticancer DDS based on liposomes and/or polymers were approved recently for clinical use, already favorably impact cancer treatments, and cost about the same as free drugs.”
- Nanotoxicology and in vitro studies: the need of the hour. (2012, background): “Growing exploration of nanotechnology has resulted in the identification of many unique properties of nanomaterials such as enhanced magnetic, catalytic, optical, electrical, and mechanical properties when compared to conventional formulations of the same material (Ferrari, 2005; Qin et al., 1999; V”
- Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform. (2008, background): “N anotechnology has been exploited extensively to enhance the pharmacokinetic properties and therapeutic index of a myriad of drugs.(1) 4 In the”